Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Rowa Pharmaceuticals Limited, Newtown, Bantry, Co. Cork, Ireland
Razole 10 mg Gastro-resistant tablets.
Pharmaceutical Form |
---|
Gastro-resistant tablet. Pink, film-coated, biconvex tablet. |
Each gastro-resistant tablet contains 10 mg rabeprazole sodium, equivalent to 9.42 mg rabeprazole.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Rabeprazole |
Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump). |
List of Excipients |
---|
Tablet core: Mannitol (E421) Intermediate Layer: Ethylcellulose (E462) Tablet coating: Hypromellose Phthalate |
Aluminium/aluminium blisters in a cardboard carton.
1, 5, 7, 14, 15, 25, 28, 30, 50, 56, 75, 98 or 120 gastro-resistant tablets.
Not all pack sizes may be marketed.
Rowa Pharmaceuticals Limited, Newtown, Bantry, Co. Cork, Ireland
PA0074/073/001
Date of first authorisation: 11th September 2009
Date of last renewal: 11th September 2014
Drug | Countries | |
---|---|---|
RAZOLE | Hong Kong, Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.